Catequentinib/programmed-cell-death-1-receptor-antagonistsAnaemia, oral mucositis and pneumonia: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1986卷 / 1期

关键词：

D O I：

10.1007/s40278-023-51430-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：125 / 125

相关论文

共 50 条

[1] Catequentinib/unspecified programmed-cell-death-1-receptor-antagonistsHypertension: case report
Reactions Weekly, 2023, 1967 (1) : 117 - 117
[2] Programmed-cell-death-1-receptor-antagonists /rituximabHypophysitis, interstitial pneumonia and rash: 3 case reports
Reactions Weekly, 2022, 1891 (1) : 257 - 257
[3] Catequentinib/SintilimabGrade 1 rash and oral mucositis: case report
Reactions Weekly, 2024, 2030 (1) : 120 - 120
[4] Programmed-cell-death-1-receptor-antagonists/rivoceranibVarious toxicities: 3 case reports
Reactions Weekly, 2020, 1833 (1) : 331 - 331
[5] Antineoplastics/programmed-cell-death-1-receptor-antagonistsNeuropathy and lack of efficacy: 3 case reports
Reactions Weekly, 2022, 1936 (1) : 81 - 81
[6] Ipilimumab/urelumab/programmed-cell-death-1-receptor-antagonistsBullous pemphigoid: 3 case reports
Reactions Weekly, 2021, 1871 (1) : 217 - 217
[7] Antituberculars/programmed cell death 1 receptor antagonistsVarious toxicities: 12 case reports
Reactions Weekly, 2020, 1815 (1) : 50 - 50
[8] Programmed-cell-death-1-receptor-antagonistsPituitary disorders: 14 case reports
Reactions Weekly, 2024, 2023 (1) : 357 - 357
[9] Panobinostat/programmed cell death-1 receptor antagonistsDevelopment of resistance in merkel cell carcinoma: 3 case reports
Reactions Weekly, 2019, 1759 (1) : 207 - 207
[10] Nedaplatin/paclitaxel/programmed-cell-death-1-receptor-expression-inhibitorsVarious toxicities: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 363 - 363

← 1 2 3 4 5 →